A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer
BackgroundProstate cancer (PCa) is one of the most prevalent cancers among males, and its mortality rate is increasing due to biochemical recurrence (BCR). Glycolysis has been proven to play an important regulatory role in tumorigenesis. Although several key regulators or predictors involved in PCa...
Main Authors: | Kaixuan Guo, Cong Lai, Juanyi Shi, Zhuang Tang, Cheng Liu, Kuiqing Li, Kewei Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.605810/full |
Similar Items
-
A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
by: Zijun Xu, et al.
Published: (2021-04-01) -
Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer
by: Daojun Lv, et al.
Published: (2021-05-01) -
Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy
by: Zhang ZN, et al.
Published: (2018-10-01) -
Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
by: Dennie Meijer, et al.
Published: (2019-07-01) -
Seven Glycolysis-Related Genes Predict the Prognosis of Patients With Pancreatic Cancer
by: Han Nie, et al.
Published: (2021-04-01)